Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

8.51
Delayed Data
As of Apr 21
 -0.37 / -4.17%
Today’s Change
8.36
Today|||52-Week Range
38.50
-41.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues2.4B2.4B2.5B2.4B
 
 
 
 
 
Cost of Goods Sold577.6M610.3M614.5M615.3M
 
 
 
 
 
Depreciation And Amortization746.8M720.1M708.6M706.7M
 
 
 
 
 
 
Operating ExpensesGross Income1.0B1.1B1.2B1.1B
 
 
 
 
 
General Expenses915.7M795.8M761.7M758.0M
 
 
 
 
 
Other Operating Expenses5.1M4.7M1.1M0.00
 
 
 
 
Research And Development103.1M124.3M100.8M93.0M
 
 
 
 
 
Total Operating Expenses2.2B2.1B2.1B2.1B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income126.4M289.3M393.7M323.0M
 
 
 
 
 
Extraordinary Credit0.0039.0M0.0031.0M
 
 
 
Extraordinary Charge-42.2M-258.8M-1.3B-208.2M
 
 
 
 
 
Interest Expense On Debt426.6M472.5M469.6M467.5M
 
 
 
 
 
Other Expenses-24.2M24.1M-2.3M-40.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-365.7M-376.8M-1.3B-360.0M
 
 
 
 
 
Income Taxes-7.2M-72.8M-113.3M-152.0M
 
 
 
 
 
Minority Interest-800.0K-1.7M-700.0K-3.0M
 
 
 
 
 
Net Income-373.7M-302.3M-1.2B-515.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS344.9M345.0M349.5M349.6M
 
 
 
 
 
Shares To Calculate EPS Diluted344.9M345.0M349.5M349.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.08-$0.88-$3.49-$1.47
 
 
 
 
 
EPS Diluted-$1.08-$0.88-$3.49-$1.47